FeesSafety
Pluang+

Brodsky & Smith investigates fairness of merger deals for Aytu BioPharma, Rapid Micro, Advantage Energy, and Canaccord Genuity.

Market News
17 Nov 2026, 17:48 WIB
GlobeNewsWire
View Source
Bearish
Brodsky & Smith investigates fairness of merger deals for Aytu BioPharma, Rapid Micro, Advantage Energy, and Canaccord Genuity.

Brodsky & Smith LLC has announced investigations into whether the boards of Aytu BioPharma, Rapid Micro Biosystems, Advantage Energy, and Canaccord Genuity breached their fiduciary duties in recent merger agreements. The investigations focus on whether these companies conducted fair processes and offered fair value to shareholders in their respective acquisition deals. Each company is being acquired by different buyers at specified cash prices per share. Investors holding shares in these companies are encouraged to contact Brodsky & Smith to discuss potential claims. These investigations could impact shareholder recoveries and highlight governance issues in merger transactions.

The Brodsky & Smith shareholder investigations into Aytu BioPharma, Rapid Micro Biosystems, Advantage Energy, and Canaccord Genuity provide context for market watchers. For readers following Financials-sector stocks on Pluang, here is the market snapshot as of Nov 17, 2026 22:41 WIB: out of 142 priced US Financials stocks, 11 rose and 130 fell. Notable movers include Deutsche Bank AG (DB) at USD 34.06, down 4.97%, Futu Holdings Ltd (FUTU) at USD 87.12, down 4.89%, and Affirm Holdings Inc (AFRM) at USD 59.94, down 4.42% with 100% sell order activity and a typical hold time of 21 days on Pluang.

More News

TD Cowen keeps Buy rating on Home Depot with $410 target after strong Q3 earnings

TD Cowen keeps Buy rating on Home Depot with $410 target after strong Q3 earnings

TD Cowen reaffirmed its Buy rating on The Home Depot, setting a price target of $410, about 19.5% above the current share price. The company reported a 4.9% sales increase to $43.4 billion and net earnings rose to $3.7 billion in Q3 fiscal 2026, driv...

Analyst Insights
Bullish
54 minutes ago
Global biotech market hits $2.02T in 2026, set to triple by 2035 amid record deals and strong Q3 growth.

Global biotech market hits $2.02T in 2026, set to triple by 2035 amid record deals and strong Q3 growth.

The global biotechnology market reached a valuation of USD 2.02 trillion in 2026 and is projected to grow to USD 6.34 trillion by 2035, driven by a 13.61% CAGR. Leading companies like Amgen, Gilead, Regeneron, Vertex, and Moderna reported strong thir...

Bullish
1 hour ago
Global metal pipe market to reach $190B by 2035, driven by construction and oil & gas demand.

Global metal pipe market to reach $190B by 2035, driven by construction and oil & gas demand.

The global metal pipe market is projected to grow at a 4.4% CAGR, reaching $190.4 billion by 2035. Growth is fueled by rising demand in construction, real estate, oil & gas, and infrastructure modernization. Technological advances, sustainability eff...

Market News
Bullish
1 hour ago
Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...

Others
Bullish
3 hours ago
RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand Company Ltd. has released its first mobile game, Palazzo Chronicles: Match 3, on the Google Play Store. The free-to-play match-3 puzzle game features over 270 levels where players restore a royal palace set in Risorgimento Italy. This launch...

Others
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App